DORINA PLACINTA: Open Payments
NPI 1033843057 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 7 | $114 |
| SCPHARMACEUTICALS INC. | 4 | $107 |
| Amgen Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| AltaThera Pharmaceuticals LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $27 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: Attruby, FUROSCIX, Repatha, LEQVIO, Sotalol Hydrochloride, Wegovy, VYNDAQEL, JARDIANCE.
Industry payments across MA — which companies pay providers there.
